In a case report, treatment with infliximab was also found to reduce HbA1c levels, increase insulin secretion, and alleviate insulin resistance in a T1D patient also diagnosed with Crohn’s disease (143). The gene discussed is INS; the disease is type 1 diabetes mellitus.